Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial

Abstract Background The Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) is a validated, disease-specific patient-reported outcome (PRO) instrument that measures symptoms and impacts experienced by patients with multiple myeloma (MM). We describe key measurement properties of the MySIm-Q...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Roberto Mina, Anne K. Mylin, Hisayuki Yokoyama, Hila Magen, Winfried Alsdorf, Leyla Shune, Iris Isufi, Simon J. Harrison, Urvi A. Shah, André De Champlain, Eva G. Katz, Katharine S. Gries, Jordan M. Schecter, Nikoletta Lendvai, Ana Slaughter, Carolina Lonardi, William Deraedt, Octavio Costa Filho, Nitin Patel, Erika Florendo, Kai Fai Ho, Lionel Karlin, Katja Weisel
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	SpringerOpen 2026-03-01
Serie:	Journal of Patient-Reported Outcomes
Soggetti:	Ciltacabtagene autoleucel Multiple myeloma Psychometric measurement properties Patient-reported outcome instrument MySIm-Q
Accesso online:	https://doi.org/10.1186/s41687-026-01034-z
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!